Evidence map›Paper›PMID 34394097›Full record

ArticleFrontiers in immunology2021

Whole Blood Interferon γ Release Is a More Sensitive Marker of Prior Exposure to

Anja Scholzen, Margot de Vries, Hans-Peter Duerr, Hendrik-Jan Roest, Ann E Sluder, Mark C Poznansky, Milou L C E Kouwijzer, Anja Garritsen

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Pre-purchase screening forFrontiers in veterinary science · 2025
    Article
  3. Cytometry profiling ofFrontiers in immunology · 2023
    Article
  4. Article
  5. Recent Advances on the Innate Immune Response toFrontiers in cellular and infection microbiology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Anja ScholzenInnatoss Laboratories B. V., Oss, Netherlands.
Margot de VriesInnatoss Laboratories B. V., Oss, Netherlands.
Hans-Peter DuerrNumerus GmbH, Tübingen, Germany.
Hendrik-Jan RoestDepartment of Bacteriology and Epidemiology, Wageningen Bioveterinary Research, Lelystad, Netherlands.
Ann E SluderVaccine and Immunotherapy Center, Massachusetts General Hospital, Boston, MA, United States.
Mark C PoznanskyVaccine and Immunotherapy Center, Massachusetts General Hospital, Boston, MA, United States.
Milou L C E KouwijzerInnatoss Laboratories B. V., Oss, Netherlands.
Anja GarritsenInnatoss Laboratories B. V., Oss, Netherlands.
Massachusetts General Hospital · USWageningen University & Research · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

For the zoonotic disease Q fever, serological analysis plays a dominant role in the diagnosis of

Indexed as

AnimalsAntibodies, BacterialAntibody FormationBiomarkersCoxiella burnetiiCross-Sectional StudiesHumansInterferon-gammaLeukocytes, MononuclearQ FeverZoonosesAntibodies, BacterialBiomarkersInterferon-gammabiomarkerCoxiella burnetiidiagnostic testexposurehumaninterferon gammaQ feverT-cell

Identifiers

PMID34394097
PMCPMC8356048
OpenAlexW3184591035

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.